The Use of Medicines in the United States: Review of 2011
We examine key issues and trends impacting consumption of and spending on medicines in the U.S. in 2011.
Providing unique and transformational insights into healthcare dynamics.
The IMS Institute for Healthcare Informatics leverages collaborative relationships in the public and private sectors to strengthen the vital role of information in advancing healthcare globally.
With access to IMS's extensive global data assets, analytics and expertise, the Institute is focused on objective, relevant insights and research that accelerate understanding and innovation critical to sound decision making and improved patient care.
Working with government agencies, academic institutions, the life sciences industry and payers, the Institute has a focused research agenda:
- Enhancing the use of information by healthcare stakeholders
- Optimizing the performance of medical care
- Understanding the future global role for biopharmaceuticals
- Supporting the role of innovation in health system products, processes and delivery systems
- Informing and advancing healthcare agendas in developing nations
Featured Insight
Brand spending has declined by $65.2 billion since 2007, but new brand spending grew to over $12 billion in 2011. Murray Aitken, Executive Director, further highlights the key components of change that drove spending on medicines last year. Listen to his commentary.
Click here for additional featured insights, updated weekly.
Applying Research
 Biopharma Insights |
|
 Health Outcomes Insights |
|
 Health Services Research Network |
Global Health Research Program
Supporting the advancement of health in low to middle income countries
We invite you to:
Featured Reports
Events & Webcasts
World Health Care Congress
Apr 16-18, 2012
Murray Aitken discusses healthcare utilization and spending patterns among the privately insured.
The Use of Medicines in the United States - A Review of 2011
